华熙生物董事长再谈“活到120岁”：十年后有望实现健康长寿

Core Viewpoint - Zhao Yan, Chairman of Huaxi Group and Huaxi Bio, emphasizes the potential for technology to enable humans to live healthily beyond 120 years, addressing chronic diseases through advancements in the next decade [1][3]. Group 1: Technological Advancements - Zhao Yan believes that major diseases, including hypertension, hyperlipidemia, hyperglycemia, high uric acid, Alzheimer's, and even tumors, can be conquered through efforts in the biotechnology field [3]. - The discussion aligns with recent advancements in anti-aging technologies, such as stem cell technology and NK cell therapy, which have shown significant progress [5]. Group 2: Public Concerns and Discussions - Public reactions to Zhao's statements reflect concerns about the implications of longevity, particularly regarding the societal burden of aging and the accessibility of medical resources [5]. - Some commentators question whether the ability to live to 120 years is a privilege for the wealthy, highlighting issues of equity in healthcare access [5]. Group 3: Systemic Challenges - Achieving the vision of overcoming chronic diseases in the next decade requires not only technological breakthroughs but also the development of healthcare systems, social security, and resource distribution [8]. - The primary threats to life, such as cardiovascular diseases, chronic lung diseases, and cancer, must be addressed in conjunction with societal readiness for an aging population [8].